What are the common anticoagulation strategies used to manage atrial fibrillation?
Common anticoagulation strategies used to manage atrial fibrillation include Vitamin K antagonists (VKAs), non-vitamin K antagonist oral anticoagulants (NOACs), and aspirin. VKAs have been the mainstay of anticoagulation therapy for atrial fibrillation, but NOACs have recently been approved by the FDA and are becoming increasingly popular. Aspirin is also commonly used as an anticoagulant in certain populations, such as those with low risk of stroke. Studies have shown that all three strategies are effective in preventing stroke in atrial fibrillation patients, but there is evidence that NOACs may be more effective than VKAs in certain populations. Additionally, it is important to note that anticoagulation strategies should be tailored to each patient's individual risk factors and medical history in order to maximize safety and efficacy.  